Cannabis Stock Explosion in Progress

Aphria, Inc. APHA – Options Recap

Our sole point of focus in terms of fresh options plays in yesterday morning’s premarket report, was a tight range of calls in the APHA chain on the heels of the company’s earning report- the APHA Weekly $10-11 Calls to be exact. Despite a down day for the markets at large, we saw this cannabis stock buck the trend on the strength of increased price targets relating to the company’s impending merger with Tilray, Inc. TLRY, another pot stock with which we’ve had some experience in the past.

The gains on our target contracts for the day yesterday were quite impressive as you’ll see below, but based on the premarket activity we’re observing this morning, we expect the following ranges and total possible gains to explode at the open today.  Read on to find the expanded set of targets that we’re going to formulate for APHA for today and into next week.

APHA Weekly $10-11 Calls
$10:
 .70-2.25 (+221%)
$10.50: .40-1.70 (+325%)
$11: .28-1.20 (+329%)

As we said above, we expect those figures to increase today, and going forward we’re going to add the APHA Weekly $13-14 Calls, and the APHA 01/22 $15 Calls into our pool of tracked contracts. We’ll also include the TLRY Weekly $21-22 Calls just for good measure.

We’re also going to include a wide range of OTC-traded cannabis penny stocks to track below, as the legislative environment is about to shift dramatically toward favorable conditions for federal reclassification, and the business opportunities it will provide should be like nothing we’ve seen to date.

______

Fresh Options Idea:
W 02/12 $340-335 Puts


OTC Cannabis Watchlist:
GRNH, TRTC, CNGT, CBMJ, HEMP, SGMD, KALY, GCAN, HMPQ, INQD, MJNA, CCAN, OWCP, UAMM, DKMR, AMMJ, SRNA, BUDZ

Blue Horseshoe Stocks: APYP Recap & More

AppYea, Inc. APYP

We re-alerted our readers on APYP on Friday morning, after having included it in our premarket report exactly two weeks ago today. It has made some good progress since then, so we’d like to kick things off this morning by providing an update on the moves it has made.

Friday’s session produced a nice intraday gain from a low of .0029 up to a new high of .0044, for a solid 52% upswing, and from the low we observed subsequent to our next most recent mention (.0009), it represented an overall increase of 389% in just under two week’s time.


Bottom-Watchlist

Both of the following stocks have recently fallen to new annual lows. We’re always on the lookout for potential bottom-bounce plays, so we’re going to want to place each of them on watch over the next few sessions.

Pain Therapeutics, Inc. PTIE – This stock underwent a massive gap-down and sell-off a couple weeks back following an FDA application denial for the extended release oxycodone capsules that the company has been licensed to develop since 2002.

We’re going to track it closely as it searches for its ultimate lows, which, if present indicators are any guide, could be forthcoming at any time now.

Cosi, Inc. COSI – While there is no gap to the upside on the COSI chart, we can see the same sort of major selloff that occurred a couple of weeks ago, and continuing up until Friday, when a new 52-week low was recorded.

As you can see on the snapshots, however, COSI is even more heavily oversold than the previously mentioned play. The volatility of its precipitous decline is what interests us most in tracking the stock for its eventual rebound.


Extended Watchlist:
GRNH, MYDX, HADV, HMPQ, JAMN, CRNT, TSRO,

Blue Horseshoe Stocks: Options Review & More

Options Updates

Under Armour, Inc. UA – On Thursday, we signaled interest in the UA Weekly $45-48 Calls and as you may recall, on that day we were provided the chance at gains spanning from 42-186% from contracts within the range. We mentioned the following morning that we expected to see further moves out of them. Our assumption proved accurate.

Multi-bag intraday gains were there for the taking, and the trading ranges in some cases exceeded any of the big gains we’d seen on Thursday by a wide margin: 

$45 Calls – Trading Range: .87-2.05 – Max Gain: 136%
$45.50 Calls – Trading Range: .54-1.54 – Max Gain: 185%
$46 Calls– Trading Range:  .20-1.10  – Max Gain: 450%
$46.50 Calls – Trading Range: .10-.57 – Max Gain: 470%
$47 Calls – Trading Range: .02-.20 – Max Gain: 900%

______

Bank of America Corp. BAC  – We were also targeting BAC options last week, namely the BAC 07/15 $15 Calls which we signaled for observation on Wednesday morning. That day we witnessed a low of .51 in those calls, and the performance was quite respectable for the remainder of the week, culminating in a high of .85 on Friday.

We’re going to want to leave this play on our radar, with so much time remaining until their expiration, we may yet see further opportunities arise.


Lithium Corp. LTUM

We also want to make a quick mention of LTUM, which appeared on our watchlist on Friday, and subsequently made a notable move.  The stock traded in a range from .10-.1349, for gains approaching 35%


Adding to the Radar

We took a look around this morning for a few new items of interest as we kick off another trading week, and came up with the following four stocks, three of which are in the biopharma sector. Half are catching our attention with fresh news out this morning, and the other half have attractive features on their charts.

FRESH NEWS:

EP Global Communications, Inc. EPGL

Johnson & Johnson Vision Care, Inc. Secures Exclusive Right of First Negotiation to EP Global Communications, Inc. Ophthalmic Technologies (Mon 7:10AM EDT)

Protea Biosciences Group Inc. PRGB

Protea announces license agreement with Yale (Mon 8:00AM EDT)

_____

INTERESTING CHARTS:

TetraLogic Pharmaceuticals Corp. TLOG  & StemCells Inc. STEM are also going on our watchlist after we’ve identified gaps on both charts in need of filling. We’re going to keep an eye on this pair over the next few sessions and see how it shakes out.


Extended Watchlist:
ADCF, ASUV, AVXL, HMPQ, ROSV, SFOR